BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會


Wan-Ting Huang

Session 6 – Pandemic Control after Vaccination (B)

Date: 22 July (Thursday)
Time: 10:40 – 12:10 (GMT+8)

Wan-Ting Huang

Science Board and Consultant
Brighton Collaboration

Dr Wan-Ting Huang obtained her MD degree from National Taiwan University. She was trained as a pediatrician and infectious disease specialist at National Taiwan University Hospital, and as an Epidemic Intelligence Service Officer at US CDC’s Immunization Safety Office. During 2006–2020, she worked at Taiwan Centers for Disease Control, the country’s responsible Agency that operates the National Immunization Program, on observational studies to inform the use of vaccines, and was engaged broadly in disease surveillance, field epidemiology, and outbreak control. Her research also focuses on long-term health impacts of prevalent and complex childhood exposures, such as diets, infections, and medications.

Dr Huang has been actively involved in several multi-country collaborative vaccine safety projects, including the US CDC Influenza Immunization and Narcolepsy Study (SOMNIA), Global Alignment of Immunization Safety in Pregnancy (GAIA) Consortium, and the Global Vaccine Data Network (GVDN). She was a member of the International Society for Pharmacoepidemiology (ISPE) Board of Directors (2012–2018) and Vaccines Special Interest Group (Chair, 2019–2020). Currently, she serves on the Brighton Collaboration Science Board, supporting harmonized safety assessment of new vaccines against emerging pathogens in the Coalition for Epidemic Preparedness Innovations (CEPI) Safety Platform for Emergency Vaccines (SPEAC) and active safety surveillance in low- and middle-income countries (LMIC) in the US CDC Safety Component of CoVID Vaccine Implementation Program (CareSafe).